An overview of the challenges and key initiatives in hepatology practice in the UK in 2022: a cautionary tale, but reasons for optimism - British Association for the Study of the Liver (BASL) Annual Meeting 2022 Conference Report.

Gemma Wells, Jessica Spiers, Felicity R Williams, Wenhao Li, Ofiver D Tavabie, Paul N Brennan

Abstract read

In one paragraph

Article in Clinical medicine (London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gemma WellsLondon North West University Hospital Trust, Harrow, London, UK.

Jessica SpiersBarts Liver Centre, Queen Mary University of London, London, UK.

Felicity R WilliamsInstitute of Inflammation and Ageing, University of Birmingham Research Laboratories, Birmingham, UK.

Wenhao LiBarts Liver Centre, Queen Mary University of London, London, UK.

Ofiver D TavabieKingston Hospital NHS Foundation Trust, Kingston upon Thames, UK.

Paul N BrennanUniversity of Dundee, Dundee, UK p.z.brennan@dundee.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mortality and working years lost from liver cirrhosis present a significant challenge both in the UK and globally. The recent British Association for the Study of the Liver (BASL) annual meeting highlighted the inequities present across the UK in terms of the burden of liver disease and access to specialist services. Innovative new ways of working and novel technologies are needed to address the growing demands of the specialty, while bearing in mind the need for sustainable and patient-focused interventions.

Indexed as

GastroenterologyHumansLiverUnited Kingdomcirrhosisdeprivationinequalityliver diseasetelemedicine

Identifiers

PMID36697015

DOI10.7861/clinmed.2022-0443

PMCPMC11046520

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.